Spectral Diagnostics (OTCMKTS:EDTXF) Stock Price Up 0.4% – Should You Buy?

Spectral Diagnostics Inc. (OTCMKTS:EDTXF) shares traded up 0.4% during trading on Wednesday . The company traded as high as $0.9998 and last traded at $0.99. 30,900 shares were traded during trading, an increase of 612% from the average session volume of 4,337 shares. The stock had previously closed at $0.9860.

Spectral Diagnostics Price Performance

The stock has a 50-day moving average price of $1.01 and a 200 day moving average price of $0.98. The firm has a market cap of $290.51 million, a price-to-earnings ratio of -9.90 and a beta of 0.09.

Spectral Diagnostics (OTCMKTS:EDTXF) last posted its earnings results on Friday, May 8th. The company reported ($0.01) EPS for the quarter, hitting analysts’ consensus estimates of ($0.01). The firm had revenue of $0.64 million for the quarter, compared to analyst estimates of $0.54 million.

About Spectral Diagnostics

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.